Exogenous addition of CCT ζ and γ subunits could therefore be of interest as a future therapy that would block the toxicity of extracellular α-syn oligomers, which are high in cerebrospinal fluid (CSF) of Parkinson patients38 and can promote prion-like spreading41. This evidence concerns the gene FLVCR2 and Parkinson disease.